| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 162,193 | 143,873 | 138,580 | 185,619 | | Cost of Revenue | 93,299 | 85,364 | 84,887 | 112,075 | | | Gross Profit | 68,894 | 58,509 | 53,693 | 73,544 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 48,250 | 39,322 | 38,916 | 53,543 | | Non Recurring | 900 |
-
| 99,514 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 19,744 | 19,187 | (84,737) | 20,001 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 149 | 442 | (4,605) | 862 | | Earnings Before Interest And Taxes | 19,893 | 19,629 | (89,342) | 20,863 | | Interest Expense | 2,375 | 3,460 | (1,429) | 3,667 | | Income Before Tax | 17,518 | 16,169 | (87,913) | 17,196 | | Income Tax Expense | 1,607 | 1,660 | 126 | 2,106 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 15,911 | 14,509 | (88,039) | 15,090 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 15,911 | 14,509 | (88,039) | 15,090 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $15,911 | $14,509 | ($88,039) | $15,090 |
|
0.51% Nasdaq 
Income Statement
